Abbott Laboratories Inc. Sustainability Profile
Abbott Laboratories Inc., commonly referred to as Abbott, is a leading global healthcare company headquartered in the United States. Founded in 1888, Abbott has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the pharmaceuticals, medical devices, nutrition, and diagnostics sectors. Abbott is renowned for its innovative products, such as the FreeStyle Libre glucose monitoring system and its extensive range of nutritional supplements. These offerings are distinguished by their commitment to quality and cutting-edge technology. With a robust market position, Abbott has achieved numerous accolades, including recognition for its contributions to diabetes care and nutritional science. As a pioneer in the healthcare industry, Abbott continues to shape the future of health and wellness globally.
DitchCarbon Score
How does Abbott Laboratories Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abbott Laboratories Inc.'s score of 54 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abbott Laboratories Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate pledges outlined in their initiatives. The absence of emissions data suggests that the company may be in the process of developing or refining its climate strategy. As a current subsidiary of Abbott Laboratories, any climate commitments or emissions data would be cascaded from the parent organisation. However, no specific targets or achievements have been reported, indicating a potential area for future development in their sustainability efforts. In the context of industry standards, Abbott Laboratories is expected to align with frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are crucial for setting credible climate targets. The lack of specific emissions figures and reduction initiatives highlights the need for enhanced transparency and commitment to climate action within the organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 578,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 691,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | 0,000,000,000 |
How Carbon Intensive is Abbott Laboratories Inc.'s Industry?
How Carbon Intensive is Abbott Laboratories Inc.'s Location?
Abbott Laboratories Inc.'s Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Abbott Laboratories Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abbott Laboratories Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
QIAGEN, Inc.
Cepheid, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.